News
Categories
Sign up
Featured Posts
Archive
- September 2020
- June 2020
- April 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- July 2019
- June 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- May 2018
- April 2018
- March 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- July 2017
- May 2017
- April 2017
- February 2017
- January 2017
Follow Us
On November 28, 2019, the first Alpha DaRT procedure was performed in Russia, at the A. Tsyb Medical Radiological Research Center in Obninsk, in a patient diagnosed with metastatic breast cancer. Radiation Oncologist Dr. Razvan Galalae from Essen, Germany, performed the treatment with the support of Prof. Yona Keisari, Chief Scientific Officer of Alpha Tau and a co-inventor of Alpha DaRT. This patient is the first in a clinical trial of Alpha DaRT just initiated in Obninsk. Breast cancer is the most common cancer among women in Russia, and is usually treated with beta or gamma radiation. Nonetheless, metastatic breast cancer is almost always fatal. Russian oncology team members who participa
In August 2018, Jonathan and Na’ama Ellman, an Israeli couple living in the United States, brought their two-year-old son Ari to the emergency room for uncontrolled vomiting. Their whole world seemed to shatter when the doctors realized that the problem was caused by a large tumor in the lower part of his brain. A complex procedure known as transnasal endoscopic skull base surgery, essentially aiming to remove the tumor through the nose, had successfully treated similar cases in the past, but had never been performed on such a young child, which presented a whole set of additional challenges. A team at the Lucile Packard Children’s Hospital in Stanford, California, agreed to perform the oper
As the new Chief Medical Officer of Alpha Tau Medical, I passionately believe that the success of our new alpha-emitting radiation therapy, Alpha DaRT, has the potential to create a paradigm shift in cancer care. Despite advances in conventional therapies, there are still many patients who succumb to their disease or who are unable to tolerate existing treatments. I am proud to be part of an Israeli startup company that is working to expand cancer care for millions of patients worldwide. Looking to make a global impact in improved patient care As I began my medical career, I chose to specialize in radiation oncology. This field specifically attracted me because it blends together three impor